These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3603898)

  • 21. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis.
    Juuti M; Alhava EM; Lammi S
    Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of lithogenic elements in urine of healthy newborns.
    Cillo AC; Cattini H; Boim MA; Schor N
    Pediatr Nephrol; 2001 Dec; 16(12):1080-3. PubMed ID: 11793105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium and citrate excretion by patients with calculi and healthy probands during induced acidosis].
    Bothor C; Berg W; Donner M; Pirlich W
    Urologe A; 1989 Mar; 28(2):112-5. PubMed ID: 2718293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Ramadan fasting on urinary risk factors for calculus formation.
    Miladipour AH; Shakhssalim N; Parvin M; Azadvari M
    Iran J Kidney Dis; 2012 Jan; 6(1):33-8. PubMed ID: 22218117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a risk for kidney stone formation in cystic fibrosis?
    Böhles H; Michalk D
    Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of sex and age in the risk of urolithiasis--a biochemical evaluation in Indian subjects.
    Sarada B; Satyanarayana U
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():365-7. PubMed ID: 1892347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis.
    Dey J; Creighton A; Lindberg JS; Fuselier HA; Kok DJ; Cole FE; Hamm L
    J Urol; 2002 Jan; 167(1):169-71. PubMed ID: 11743298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Circadian rhythms of lithogenic and inhibitory substances in the urine].
    Ebisuno S; Morimoto S; Yasukawa S; Yoshida T; Fukatani T; Minakata S; Uehara M; Ohkawa T
    Hinyokika Kiyo; 1986 May; 32(5):667-71. PubMed ID: 3751794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.